Five key drug discovery appointments

1. Antonin (Tony) de Fougerolles, Etherna 

Antonin (Tony) de Fougerolles has joined the Etherna board of directors as an independent member. 

He is currently the CEO of Evox Therapeutics. As founding Chief Scientific Officer (CSO) at Moderna Therapeutics, he pioneered modified mRNA. 

2. Dr Xavier Jacq, Ubiquigent

Ubiquigent has appointed Dr Xavier Jacq to its Scientific Advisory Board (SAB).

Dr Jacq co-founded Mission Therapeutics, where he held the positions of VP Scientific Affairs and Director of Biology. 

He is currently Chief Scientific Officer at moa Technology.

3. Simon Fricker, Pepper Bio

Pepper Bio has added Simon Fricker as Chief Development Officer. 

Previously, Dr Fricker served three years as Vice President of Research and Development at Phio Pharmaceuticals, and eight years as a distinguished scientific fellow at Genzyme/Sanofi. 

4. Richard Hammond, Sphere Fluidics

Sphere Fluidics has appointed Richard Hammond as Chief Technical Officer. 

Hammond joins Sphere Fluidics with over 20 years’ experience in numerous senior positions, including leading product and technology development at Alere, Cambridge Consultants and DNA Electronics. 

5. Dr Paul Brooks, CN Bio

Dr Paul Brooks, formerly CN Bio’s Chief Business Officer, has been appointed as CEO. The former CEO, Dr David Hughes, will take on a consultative role within the company’s Scientific Advisory Board.

Prior to joining CN Bio, Dr Brooks was Head of Business Operations & Managing Director for PerkinElmer’s Horizon Discovery.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free